Home › Lung Diseases › Texas
Lung Diseases clinical trials in Texas
22 studies for Lung Diseases are looking for participants at sites in Texas.
Cities in Texas
A Study of COVID-19 Vaccine(s) in Children and Adults
- Cedar Health Research, Dallas
- Cedar Health Research, Euless
- DM Clinical Research-Cyfair, Houston
- and 1 more
RecruitingPhase 3Healthy volunteers welcome
Ages 5 and older · All sexes · Updated Sep 28, 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Zenos Clinical Research, Dallas
- Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
- Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Premier Pulmonary Critical Care and Sleep, Denison
- Baylor College of Medicine Medical Center, Houston
- Prime Clinical Research - Lewisville, Lewisville
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Zenos Clinical Research, Dallas
- Southwest Family Medicine Associates, Dallas
- Southwest Mind and Body Care, Dallas
- and 9 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140American Lung Association (ALA) Lung Health Cohort
- Baylor College of Medicine, Houston
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Sep 23, 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Horizon Clinical Research Group, Cypress
- Alina Clinical Trials, LLC., Dallas
- and 2 more
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- MD Anderson, Houston
- NEXT Dallas, Irving
- NEXT Oncology San Antonio, San Antonio
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
- Site 1005, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07407933A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Texas Oncology, Austin
- William Beaumont Army Medical Center, Fort Bliss
- Houston Methodist Hospital, Houston
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Houston
- GSK Investigational Site, Temple
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06572384Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Baylor College of Medicine, Houston
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
- Renovatio Clinical, The Woodlands
- Renovatio Clinical, Webster
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Houston
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT05967689Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Amarillo
- Research Site, Dallas
- Research Site, El Paso
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05624450A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Lewisville
- Research Site, San Antonio
RecruitingPhase 2
Ages 4 to 11 · All sexes · Updated Aug 27, 2026 · NCT07525375A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07555483A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- St. David's South Austin Medical Center, Austin
- UT Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- UT Southwestern Clements University Hospital, Dallas
Recruiting
Ages 18 to 80 · All sexes · Updated Nov 4, 2025 · NCT04164173From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.